Randomized comparison of atenolol and placebo in the treatment of anxiety: A double-blind study

P. Saul, B. P. Jones, K. G. Edwards and J. A. Tweed

View Related Documents

Abstract

In a randomized double-blind prospective between-patients trial in patients presenting with primary anxiety, atenolol significantly improved mean values on the Hamilton rating scale at two and four weeks when compared with placebo. There was also a significant improvement in affective symptoms at 28 days for atenolol when compared with placebo.

Key words  anxiety - atenolol -  beta-blockers

Fulltext Preview

Image of the first page of the fulltext document